← Back to All Stocks

ABT - Abbott Laboratories

Health Care

Price History

About

Industry

Medical Devices

Employees

115,000

Headquarters

United States


Company Overview

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. The company also provides cancer screening and diagnostic test products. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Price

$102.67

52-Week Range

$101 $139

Dividend Yield

2.47%

Dividend Score

A

Dividend

Yield 2.47%
Annual $2.52
Payout 63%
5Y Avg 1.75%

Valuation

P/E (TTM) 27.6
Fwd P/E 16.8
P/B 3.42
PEG N/A

Profitability

Profit Margin 14.7%
Op Margin 21.6%
ROE 13.0%
ROA 6.6%

Financial Health

Current Ratio 1.58
Quick Ratio 1.02
Debt/Equity 27%

Cash Flow

Free CF $6.3B
Op CF $9.6B
Total Cash $8.9B

Analyst Consensus

Buy

25 analysts

Target: $133 $113 - $158
+29.2% implied

Dividend Growth

Most Recent Annual Growth

7.27%

3-Year Avg Growth

7.87%

5-Year Avg Growth

10.61%

Annual Dividends

Year-over-Year Growth

Recent Dividend History

Ex-Dividend Date Amount
Jan 15, 2026 $0.6300
Oct 15, 2025 $0.5900
Jul 15, 2025 $0.5900
Apr 15, 2025 $0.5900
Jan 15, 2025 $0.5900
Oct 15, 2024 $0.5500
Jul 15, 2024 $0.5500
Apr 12, 2024 $0.5500
Jan 11, 2024 $0.5500
Oct 12, 2023 $0.5100
Jul 13, 2023 $0.5100
Apr 13, 2023 $0.5100
Jan 12, 2023 $0.5100
Oct 13, 2022 $0.4700
Jul 14, 2022 $0.4700
Apr 13, 2022 $0.4700
Jan 13, 2022 $0.4700
Oct 14, 2021 $0.4500
Jul 14, 2021 $0.4500
Apr 14, 2021 $0.4500

Unlock Full Access

Get unlimited access to all features including our powerful dividend screener, detailed stock analysis, and our dividend growth forecasting tool.

Full Screener

300+ proven dividend growth stocks

Growth Forecasts

Project returns with reinvestment

Deep Analysis

Fundamentals & metrics that matter